These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28731284)

  • 1. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
    Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
    Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
    Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
    Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
    Zhang Z; Huang A; Zhang A; Zhou C
    Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
    Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
    Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
    Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
    Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
    Guo X; Hartley RS
    Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
    Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
    Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for ezrin in breast cancer cell chemotaxis to CCL5.
    Li J; Tu Y; Wen J; Yao F; Wei W; Sun S
    Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
    Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
    Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HuR controls glutaminase RNA metabolism.
    Adamoski D; M Dos Reis L; Mafra ACP; Corrêa-da-Silva F; Moraes-Vieira PMM; Berindan-Neagoe I; Calin GA; Dias SMG
    Nat Commun; 2024 Jul; 15(1):5620. PubMed ID: 38965208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer.
    Zhang Q; Qin J; Zhong L; Gong L; Zhang B; Zhang Y; Gao WQ
    Cancer Res; 2015 Oct; 75(20):4312-21. PubMed ID: 26249173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
    Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
    Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.
    Wei H; Wu X; Huang L; Long C; Lu Q; Huang Z; Huang Y; Li W; Pu J
    J Hepatocell Carcinoma; 2024; 11():543-562. PubMed ID: 38496248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
    Zhu YY; Zhao YC; Chen C; Xie M
    Gene; 2022 Feb; 812():146100. PubMed ID: 34864094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
    Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
    Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
    Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
    J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
    Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
    Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.